产前局限性过度生长障碍的临床与分子数据:PI3K-AKT-mTOR信号通路基因变异的重要影响
本研究回顾性分析法国多中心2013至2020年产前诊断疑似局限性过度生长障碍(LOD)的21例胎儿,利用尸检病理组织进行PI3K-AKT-mTOR通路基因二代测序。孤立性巨脑回或半侧巨脑回可发现该通路基因变异,肢体过度生长合并淋巴管畸形或孤立性半侧巨脑回可能与PIK3CA变异相关。羊水细胞测序在10例中4例检出变异。
要点
- 孤立性巨脑回或半侧巨脑回胎儿应检测PI3K-AKT-mTOR通路基因。
- 肢体过度生长合并淋巴管畸形或孤立性半侧巨脑回可能与PIK3CA变异相关。
- 羊水细胞二代测序可作为产前分子诊断的辅助手段。
核心结论
- 孤立性巨脑回或半侧巨脑回可发现PI3K-AKT-mTOR信号通路基因变异。
- 肢体过度生长合并淋巴管畸形或孤立性半侧巨脑回可能与PIK3CA变异相关。
研究设计与样本
- 回顾性分析法国多中心2013年1月1日至2020年5月1日产前诊断疑似LOD的21例胎儿。
- 利用胎儿尸检病理组织对PI3K-AKT-mTOR通路基因进行二代测序(NGS)。
- 评估10例羊水细胞NGS的诊断效能。
主要发现
- 21例中17例有脑过度生长,包括6例孤立性巨脑回(MEG)和11例半侧巨脑回(HMEG)。
- 6例MEG中4例检出胚系变异(PIK3R2、AKT3或MTOR),另2例检出PIK3R2突变。
- 11例HMEG中3例有PIK3CA相关过度生长谱 extracerebral表现者检出PIK3CA突变,7例孤立性HMEG检出PIK3CA突变,1例未检出致病性变异。
- 4例肢体过度生长合并淋巴管畸形(LM)者检出PIK3CA突变。
- 10例羊水细胞NGS中4例检出变异(PIK3CA、PIK3R2或AKT3)。
临床怎么用
- 对产前发现孤立性MEG或HMEG的胎儿,应考虑检测PI3K-AKT-mTOR通路基因。
- 肢体过度生长合并LM或孤立性HMEG时,应重点关注PIK3CA变异。
- 羊水细胞NGS可作为产前分子诊断的辅助方法。
局限性
- 回顾性研究,样本量较小(21例)。
- 羊水细胞NGS仅评估10例,诊断效能需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe clinical and molecular findings in a French multicenter cohort of fetuses with prenatal diagnosis of congenital abnormality and suspicion of a localized overgrowth disorder (LOD) suggestive of genetic variants in the PI3K-AKT-mTOR signaling pathway. METHODS: We analyzed retrospectively data obtained between 1 January 2013 and 1 May 2020 from fetuses with brain and/or limb overgrowth referred for molecular diagnosis of PI3K-AKT-mTOR pathway genes by next-generation sequencing (NGS) using pathological tissue obtained by fetal autopsy. We also assessed the diagnostic yield of amniotic fluid. RESULTS: During the study period, 21 subjects with LOD suspected of being secondary to a genetic variant of the PI3K-AKT-mTOR pathway were referred for analysis. Of these, 17 fetuses had brain overgrowth, including six with isolated megalencephaly (MEG) and 11 with hemimegalencephaly (HMEG). Of the six with MEG, germline variants were identified in four cases, in either PIK3R2, AKT3 or MTOR, and a postzygotic PIK3R2 variant was found in the other two cases. Of the 11 with HMEG, a postzygotic PIK3CA variant was found in three fetuses with extracerebral features of PIK3CA-related overgrowth spectrum, and in seven fetuses with isolated HMEG. No pathogenic variant was identified in the 11th case with HMEG. Four fetuses with limb overgrowth also had one or more lymphatic malformations (LM) and harbored a postzygotic PIK3CA variant. NGS on cultured amniocytes performed in 10 cases, of which nine had been found positive on analysis of pathological fetal tissue, showed variants in four, in either PIK3CA, PIK3R2 or AKT3. CONCLUSIONS: Isolated MEG or HMEG may lead to identification of genetic variants in the PI3K-AKT-mTOR signaling pathway. Cases of limb overgrowth and LM or isolated HMEG are likely associated with PIK3CA variants. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Bourgon N, Carmignac V, Sorlin A, et al. Clinical and molecular data in cases of prenatal localized overgrowth disorder: major implication of genetic variants in PI3K-AKT-mTOR signaling pathway. Ultrasound Obstet Gynecol. 2022. PMID: 34170046. doi:10.1002/uog.23715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。